UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

Cohen, Hannah; Werring, David J; Chandretheva, Arvind; Mittal, Prabal; Devreese, Katrien MJ; Isenberg, David A; ISTH SSC LA/aPL Subcommittee Study Group; (2023) Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Journal of Thrombosis and Haemostasis , 21 (10) pp. 2963-2976. 10.1016/j.jtha.2023.06.020.

[thumbnail of Efthymiou_01 - Manuscript DIAPS APS ACTION 2023-01-30 (1)ME.pdf] Text
Efthymiou_01 - Manuscript DIAPS APS ACTION 2023-01-30 (1)ME.pdf
Access restricted to UCL open access staff until 29 June 2024.

Download (584kB)

Abstract

BACKGROUND: The optimal strategy for diagnosis and antithrombotic treatment of patients with antiphospholipid syndrome (APS)-associated acute ischaemic stroke (AIS), transient ischaemic attack (TIA) or other brain ischaemic injury is poorly defined. OBJECTIVES: The survey goal was to capture variations in diagnosis and antithrombotic treatment of APS-associated ischaemic stroke and related disorders, to inform guidance and clinical trials to define optimal management. METHODS: Key opinion leaders/workers were invited to complete a REDCap survey questionnaire initiated by the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. The survey data were tallied using simple descriptive statistics. RESULTS: There was generally good agreement on several aspects, including which patients to test for antiphospholipid antibodies (aPL); use of lifelong vitamin K antagonist for AIS or recurrent TIA; and formal cognitive assessment for suspected cognitive impairment. There was less agreement on other aspects, including aPL testing for brain ischaemic injury other than AIS/TIA, or if an alternative cause for AIS or TIA exists; choice of aPL tests, their timing and age cut-off; the aPL phenotype to trigger antithrombotic treatment; management for patent foramen ovale; antithrombotic treatment for first TIA or white matter hyperintensities; head magnetic resonance imaging specifications; low-molecular-weight heparin dosing/anti-Xa monitoring in pregnancy. The survey highlighted that approximately 25% do dedicated APS clinics and <50% have a multidisciplinary team structure for APS patients. CONCLUSIONS: Much of the variation in practice reflects the lack of evidence-based recommendations. The survey results should inform the development of a more uniform multidisciplinary consensus approach to diagnosis and antithrombotic treatment.

Type: Article
Title: Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
Location: England
DOI: 10.1016/j.jtha.2023.06.020
Publisher version: https://doi.org/10.1016/j.jtha.2023.06.020
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Antiphospholipid syndrome, cerebral infarcts, ischaemic stroke, survey, transient ischaemic attack, white matter hyperintensities
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Brain Repair and Rehabilitation
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10177845
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item